SCHEMBL7963970

SCHEMBL7963970

COc1ccc2c(CC(N)=O)c(C)n(Cc3ccccc3)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 19/20 1.00
PLA2G1B P04054 1/20 0.69
PLA2G10 O15496 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953243 0.91 PLA2G2A (1.00) PLA2G2APLA2G1B
SCHEMBL7962188 0.86 PLA2G2A (0.80) PLA2G2A
SCHEMBL7953209 0.85 PLA2G2A (1.00) PLA2G2A
SCHEMBL8924460 0.85 PLA2G2A (0.74) PLA2G2A
SCHEMBL7964499 0.85 PLA2G2A (1.00) PLA2G2A
SCHEMBL7966026 0.84 PLA2G2A (1.00) PLA2G2A
SCHEMBL7965081 0.84 PLA2G2A (0.86) PLA2G2APLA2G1B
SCHEMBL8924528 0.84 PLA2G2A (0.71) PLA2G2APLA2G10
SCHEMBL8926192 0.84 PLA2G2A (0.71) PLA2G2A
SCHEMBL29941473 0.83 PLA2G2A (0.75) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252084-B1 THERAPY FOR SEPSIS SHOCK ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0620215-B1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors LILLY CO ELI (US) 1999-08-18 EP disclosed
US-5684034-A INHIBITORS OF HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2, TREATMENT OF SEPTIC SHOCK, TRAUMA, RESPIRATORY DISORDERS, RHEUMATIC ARTHRITIS, INHIBITORS OF ARACHIDONIC ACID RELEASE ELI LILLY AND COMPANY (US) 1997-11-04 US disclosed
EP-0620215-A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed